Antonio Colombo, MD
Director Cardiac Catheterization Laboratory
San Raffaele Hospital
San Raffaele Hospital
Member of the Healthcare Council
Antonio Colombo, MD, is Director of the Cardiac Catheterization Laboratory at Columbus Hospital and San Raffaele Hospital in Milan, Italy. Dr. Colombo is also a Visiting Professor of Medicine at Columbia University Hospital and Professor of Clinical Medicine at New York University. He has extensive experience in coronary interventions and drug eluting stents. Dr. Colombo is on the editorial board of various journals, including Circulation, International Journal of Cardiovascular Intervention, and Journal of American College of Cardiology. (This is me - Update Profile)
| 1998 - present | Director Cardiac Catheterization Laboratory San Raffaele Hospital |
|---|---|
| 1996 - present | Professor of Clinical Medicine New York University (inc) |
| 1986 - present | Chief of Cath Lab Columbus Hospital |
GLG Study Groups with Antonio Colombo, MD(?)
| Study Group Name | Members |
|---|---|
| Physicians who Implant the COSTAR Drug Eluting Stent | 29 |
| Interventional Cardiologists (EU) | 205 |
| Physicians who Implant Taxus Stents | 96 |
| Cardiologists (EU) | 820 |
GLG NewsSM Analyses by Antonio Colombo, MD(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Antonio Colombo, MD has not published any public GLG News analyses.
View all GLG News in Healthcare
View all GLG News in Healthcare
GLG InstituteSM Seminars with Antonio Colombo, MD(?)
Antonio Colombo, MD has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare
View all GLG InstituteSM Seminars in Healthcare
Request a project with Antonio Colombo, MD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
40 of the leading 50
global mutual funds
global mutual funds
15 of the leading 20
global banks
global banks
8 of the leading 10
private equity firms
private equity firms
90%+ client subscription renewal rate

